Ledger.Open graph →
SEC Form D · filed March 31, 2022

Cognos Therapeutics Inc

Offering
$2.1M
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
INGLEWOOD, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Frank Adell · Inglewood, CAExec · DirectorThomas Chen · Inglewood, CADirectorEli Gang · Inglewood, CADirectorJosh Shachar · Inglewood, CADirectorAshton Levarek · PHOENIX, AZDirectorTally Ringwood · Salt Lake City, UTDirectorCarl Ager · SALT LAKE CITY, UTDirectorGuilherme Cherman Perdigao De Oliveira · Syracuse, NYExec · DirectorMekaelia Davis · New York, NYExec · DirectorKent Mcneil · Austin, TXDirectorJohn Burns · Austin, TXDirectorBrian P. Fogarty · Radnor, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗